CMC

DKDamian

Oh, sure, and I have thought about it. I use CMC and occasionally buy single US stocks. Didn’t buy Nvidia. Oh well. I did buy Google quite cheap, which was nice

blalah

It's wild. Market sentiment in the toilet on CMC while most bagholders are up over 100% and more

BeneficialSort9477

About time to jump into $MIST, superb price right now PDUFA in Dec, last round CRL with only CMC issues, highest approval likelihood that we've seen in a while

blalah

still way too much confidence that CMC fear/greed index has got to be broken. I would say extreme fear would start to exist if it consolidated back near 50k

Current-Friend-3943

Could be a few reasons, for me it was my broker. By broker's chart was severely delayed since it is primarily an AUD broker, so while my sell order was set at lets say .50c the chart showed .80c but the actual price was like .40. I now have both CMC up and a more accurate live chart to track the price more accurately. I have never heard of Etrade, and with how many options of brokers out there that are more reliable why can't you change? Could also be volume, if you are selling at a downward trend on something where no one is buying then you might get stuck holding until buying interest returns. Doesn't matter how cheap something is, if no one wants it it may as well be worthless. Don't amend your sell order. Set it at something and be happy with the loss. Don't try to catch the knife on the fall, by cancelling your sell order and re selling you essentially rejoin the queue and have lower sell priority. Ways to mitigate this issue is to - like you said sell in increments or set up a trailing stop loss like a few percentages behind the price. Sure the price might drop and buy your shares then take off and it does suck knowing you could have been up such and such but learn to be happy with profits no matter how small. Your win is someone else losing, may as well win.

Phyrodox

Posted yesterday, but MIST is a great option for those into swing trading. Very high likelihood of FDA approval on the 13th December after addressing CMC issues causing their CRL. Unmet clinical need in a rare pathology. I've got 2,500 shares and picking more up on this week's dip. NFA

WickedDeviled

Just snagged some $CMC 65's - see where it goes.

Stocks_N_Bondage

Calls: UAL TSM INFY CMC Puts: TRV JBHT

the_snook

> I live in Australia, and use Revoult to invest You will probably find it much easier at tax time if you use an Australian platform that provides the correct tax statements for your investments. Do a search on /r/AusFinance for suggestions (CMC Invest and Betashares Direct are popular low-fee options, but there are a number of others).

No_Weakness_5888

Well, average price estimate is 50$, I guess 10x is a great upside.  Also, it is likely the company gets the approval. The CRL has only CMC issues and nothing regarding the drug, so I think the rejection in Dec is an unlikely event. Or what is your opinion?

ConsistentCherry9519

Guys I have £1500 to try to change mine and my toddlers life. Where should I invest? I use CMC. I would sooo appreciate you guys feedback ❤️

PreludeTilTheEnd

Buy the stock get warrant. Each REGISTERED SHAREHOLDER as of the Record Date will receive one (1) warrant for every ten (10) shares of GameStop common stock held, rounded down to the nearest whole warrant. The warrants will be distributed on October 7, 2025, tradeable on the NYSE under ticker GME WS, and allow holders to buy one share of GameStop stock at $32 until October 30, 2026. --List of broker that support warrants-- Robinhood: No, does not support warrants. * Updated - call to RH confirms support of warrants Wealthsimple: No, limited to stocks/ETFs, no warrants. * updated- will soon support warrants Fidelity: Yes, supports receiving and trading warrants as part of corporate actions. Charles Schwab (including TD Ameritrade): Yes, handles warrants trading and distributions. E*TRADE (Morgan Stanley): Yes, supports warrant purchases and corporate action distributions. Interactive Brokers: Yes, advanced support for trading warrants globally. Webull: Yes, allows trading of listed warrants. Ally Invest: Yes, supports warrants as part of options-like trading. Firstrade: Yes, enables warrant trading. Questrade: Yes, Canadian brokerage that discusses and supports warrant exercises. CapTrader: Yes, specializes in warrant trading access. CMC Markets: Yes, offers warrant trading platforms.

Delicious-Fan-2539

$CMC is far better option than $sg. Its trading at lows and doing aggressive share buyback

Unterhund70

Sorry for the long response... Your comment covers a lot of ground in few words! This should probably go out as a post, but maybe for another day. CD388 is the first clinical proof-point for drug-Fc conjugates (DFC) on the Cloudbreak scaffold. The value isn’t just the influenza asset; it’s the repeatable toolkit—Fc-engineering, targeting domains, linker chemistry, and manufacturability—that can be retargeted to new pathogens/indications. Once the chassis is validated in humans (which Phase 2b just did), it is reasonable to expect follow-ons to be faster and cheaper to advance than the first one. I certainly agree that Cidara isn’t getting credit for this at this time. I am looking forward to seeing what they do with their oncology asset now that this proof point has passed with flying colors. Do they not have more of a moat than you suggest? Saying “any big pharma could copy it” assigns no value to: • IP stack depth: composition-of-matter, method-of-use, and manufacturing claims across Fc variants, linkers, and targets. • Know-how + CMC: reproducible large-scale Fc conjugation with preserved effector function is non-trivial, I expect; tech-transfer takes time even for a major pharmaceutical. • Data moat: real-world human efficacy/safety on the same scaffold is proprietary and compounds over time. Even if a big company can build a similar architecture, the economically rational path is usually partnering or acquiring the validated platform. For a single asset, sure: (1) does it work, (2) who pays, (3) runway makes sense. For a platform, I would also look for: • Repeatability: how quickly can the engine generate the next asset? • Option value: what’s the TAM across multiple pathogens/indications? • Partner pull: are strategic partners engaging now that human proof-point exists? Those are the drivers behind platform multiples (and why markets should re-rate after platform PoC, IMO). In my valuation analysis, I’ve focused on CD388 only because the valuation disconnect is already big enough to question without looking at the broader platform. For influenza prophylaxis in high-risk cohorts (transplant, elderly, immunocompromised), payers already reimburse high-value prevention (e.g., mAbs, high-dose vaccines). A long-acting, pre-exposure DFC with strong efficacy fills a real gap and is economically attractive compared to hospitalizations and lost capacity in peak season. That’s a market design question—not a binary “will anyone will pay” question, and I would have thought should deserve a more measured risk discount. Investors seem still to be pricing for binary risk. Runway extends via grants, BARDA/NIH programs, and partner capital—the standard playbook for platform biotechs post-PoC. The next catalyst (EOP2 → Phase 3 design) is exactly what unlocks those pools. Again, not binary but risk discounted, sure. I agree with your comment about ATYR: when the drug doesn’t work, sentiment breaks. With CDTX, the drug apparently works and a platform POC was successfully demonstrated. Sentiment? Meh… INSM got its re-rating when it proved it could execute repeatedly and expand its addressable market. That’s the path I'd expect a platform play to follow post-PoC. I agree that CDTX is just getting started down that path and that the re-rating to a platform play will happen over time as proof points emerge. Right now, I am just questioning why the market is discounting the value of just their flu asset by what seems to be an excessive amount. Bottom line: On the question of moat, I have a different take; Calling Cloudbreak “copyable” and Cidara “a single-drug bet” I believe under values the technical/IP/CMC/data that are the moat and the fact that CD388 validates the chassis. The investment case now, IMO, is whether management converts that PoC into (a) Phase 3 execution, (b) partner pull, and (c) pipeline repeatability. That’s a platform thesis—not a one-asset story.

Avish_Golakiya

As some of you asked about how I pick up, my approach is pretty simple and repeatable, clear, near-dated catalysts with real endpoints; clean financing (runway, no toxic ATM activity); sane float/liquidity; EV vs assets sanity check; and tape that isn’t brittle. PoA is a weight, not the driver. I still read the prior class readouts and watch for AdCom/CMC landmines. I’m mostly event-driven, size small, like the run-up window, and usually de-risk before the binary unless I’ve got a real edge.

jcrulez143143

Puts on CMC

Zealousideal-Ear569

get it on CMC Invest.

JaySavy

I’d just stay away from CMC. Go get your RB’s early

TheXamYel

Puts on CMC

Purple_Bearkat

CMC’s backup 💪

Best-Bodybuilder9015

Initial FDA review and setback Outlook Therapeutics initially submitted a Biologics License Application (BLA), but the FDA issued a Complete Response Letter (CRL) in August 2023. Key issues cited included deficiencies in chemistry, manufacturing, and controls (CMC), preapproval inspection findings, and the need for additional confirmatory clinical data

Crazy_Willingness_96

The reality is that as a retail investor with no direct access to management or KOL you can’t do real due diligence. You have no idea what the FDA feedback has been in meetings with the company. You don’t have access to CMC prep that the company has done with its ph3 You don’t know if the trial has been designed to be powered adequately, or if the endpoint is deliverable / approvable. Look at ixhl which is being trumpeted about on this forum. Supposedly moving to oh3, supposedly good ph2 data. They have no data comparing to CPAP. No clear path to delivering data that meets an unmet need.

Avish_Golakiya

I tends to with 70-30. 30% high risk high rewards and the rest commercial biotechs. Also I some time buy 52-week low on CRL basically FDA rejection if the reason is not scientific rather operations or CMC

kent_chambers

You can trade them with CMC Markets. Margin requirement is $2,000 to get started. Some people have said invest in West Fraser, I’d run. I’m fact I’d run from trading futures too. The cost to hold contracts on CMC is very expensive so any long term trades are counterproductive. You need to trade quick in and out on volatile days to make money. If you want to go long at the bottom of the market somewhere in the low 500’s on an actual contract through interactive brokers with 30,000 margin requirement then go for it. I’d go short at 700.

statitica

I've been looking at this option, and CMC Markets. I did see some mentions that IBKR's interfaces are not super user friendly but that's not a huge hurdle for me. I also saw some mention that it is geared towards "very active" investors, which I don't imagine I will be - at least to begin with. Do I need to be making a lot of trades to reap the benefits of the platform, or will the benefits just get multiplied at higher trade volume?

Ga_glovo

Not true, all phases for PSVT were completed and were successful, FDA found no safety nor efficiency issues for the drug - only minor CMC, furthermore more phase 2 was completed for afib. They are very near approval for PSVT treatment - btw today NDA resubmission is accepted and I think we have much bigger chances of approval than on 28 March.

VlkXai

Would anyone know any UK brokers that have SYNX? Checked CMC market, trading212 but nada, thanks.

doroknoth

CMC calls or puts? feels like calls because steel

blalah

Partially. The other half was crypto, which kind of doesn't belong here, but the price swings are almost scripted. Pick literally anything in the top 50 of CMC that is down 10 to 10% for the day and you can immediately recoup that difference within the next week. There must be black swans but I haven't found one yet.

DecisionNo1902

A lot of platform are already doing it CMC have around 80 (top stokes). Personally I don't use CMC, its got awful reviews, and working for them is worse. IG .com have had all session trading for a few years and they have about Robinhood as well

Helios330

WBD: Trading under book value, I like the IP, and I like HBO Max GOOGL: AI Trade RDTL: AI Trade and hoping numbers get pumped in the upcoming quarter with the recent changes to google search WRB, CMC, NOMD: stock I like, but don’t really care to buy more than a share of rn (just don’t wanna forget about them completely lol) TSLA, LYFT: Waymo is going to be the nail in the coffin for both of these. I am shorting both. Also, all recent global Tesla sales info looks horrendous

1UpUrBum

It depends what you need from the brokerage. QTrade, Ninga, AMP, CMC are probably the best in their respective areas.

KAY-toe

>China has the National People’s Congress system, where the head of state is elected by people’s representatives, yet you say China is not democratic. A friend who used to be a low-ranking CCP member and is now a US citizen explained the basic mechanics of China’s political machine to me. NPC is a party-controlled system, again “representatives” is not the same as “chosen representatives“, citizens have no say beyond county-level deputies and at the highest level are represented by whoever the party wants representing them. On Election Day I receive a ballot with presidential candidates’ names on it, no Chinese citizen does, nor for NPC, Central Committee, or any other position of consequence. Xi eliminated term limits, then was nominated by near-unanimous votes ever since - in 2023 he won by nearly 3,000 votes to precisely 0 - does that sound like a healthy democracy? It’s not competitive voting, it’s not like there’s an alternative candidate he competes against who got the 0 votes, it’s just Xi who was nominated and NPC members (also not on any citizens ballots) can vote for or against. The presidency is a moot point anyways, his being GS of CCP and CMC Chair are what give him his power. Again, those positions are not chosen by real elections either, but rather more near-100% agreement by the Central Committee and NPC. I’m not even clear why you want to call China’s system democratic or say I’m wrong saying it’s not - the system is what it is and has its strengths and weaknesses, citizens voting for their national leadership is simply not one of its features. The US has its own unfortunate spins on this as well, such as the electoral college. But China’s culture is far more collectivist, in my experience this doesn’t seem to bother their citizens to the extent it would Americans. >In my view, the prerequisite for democracy is that the public has access to correct information. Without this prerequisite, all so-called democracy is fake democracy. I agree about democracies requiring truth to function correctly, this is why seeing hyper-polarized Western news outlets is so disturbing, they effectively act like state-run media for a single party. >In this world, the control of media by capital and governments can distort the normal functioning of democracy from its very source. Yes, Xinhua, RT, or any single-party news source is bad for democracies because they give the public propaganda under the guise of journalism. Fox and CNN today will both dry your brain and are far less healthy for the US than they were 20 years ago as both have moved further and further from center. >For example, although most Americans have never been to China or Russia, they can believe all negative information about China, and vice versa. Most Chinese have never been to the U.S., but in China, due to media guidance, a considerable number of Chinese believe the U.S. is a paradise on earth, while many others inexplicably hate Americans. Many Americans also have little grasp of other countries’ actual living conditions and tend to assume everywhere else is poor. Xenophobia is influenced by many other cultural factors also, unfortunately we recently saw very clearly that there are Americans who hate not only Chinese people but Asians broadly. The spike in violence here against Chinese- and other Asian-Americans during COVID was sickening. >This passage perfectly illustrates how an American who knows nothing about China can easily make their own judgments. If you can find a source of credible data for COVID deaths in China I’d give it an honest look and am quite familiar with epidemiological sampling and studies, but the state-released numbers I’ve heard were not defensible.

bluetuxedo22

On a side note to anyone reading this, I've never traded in puts or calls before. What and where is the safest way to learn the basics? I buy shares on CMC markets, but I don't understand much beyond the basics of buying and selling.

Maxcharged

Anyone see a steel importer more at risk than CMC? CMC has factories in EU and US, Will they be cooked if the EU retaliates?

Independent-Theory10

CMC invest is not a bad way to go :)

dtaromei

How are you so sure that they will get approved? It could be like the MIST situation where the FDA issues a complete response letter and that caused their stock to crash more than 60% in a single day. It was not even that they were not approved, it was due to two key Chemistry, Manufacturing and Controls (CMC) issues

Impossible-Hair1343

MONTREAL and CHARLOTTE, N.C., March 28, 2025 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for CARDAMYST™ (etripamil) nasal spray, a prescription medication in development for the conversion of acute episodes of PSVT to sinus rhythm in adults. The FDA did not raise any concerns regarding etripamil clinical safety or efficacy data and highlighted two key Chemistry, Manufacturing and Controls (CMC) issues to be addressed: Company to submit additional information on nitrosamine impurities based on new draft guidance issued after the NDA submission; and An inspection is required at a facility that performs release testing for etripamil, to ensure it is in compliance with Current Good Manufacturing Practices. The facility changed ownership during the review of the NDA.

Ga_glovo

me too but I am not selling - this is not a rejection - no safety and efficiency issues the drug works - CMC resolved this goes back over 2.25 and hist at least 3-5 USD a share

Ga_glovo

if you have free money, buy more - I do not have and will wait for recovery. They have enough cash at least until end of the first half of 2026...CMC is minor issue here

Ga_glovo

They were expecting to be liquid even with approval all until the end of 2026 - now with delay, they will have no selling nor RD costs so liquidity should not be an issue and CMC are not big issues in this case...

GeorgeTran1999

The FDA did not raise any concerns regarding etripamil clinical safety or efficacy data and highlighted two key Chemistry, Manufacturing and Controls (CMC) issues to be addressed: Company to submit additional information on nitrosamine impurities based on new draft guidance issued after the NDA submission; and An inspection is required at a facility that performs release testing for etripamil, to ensure it is in compliance with Current Good Manufacturing Practices. The facility changed ownership during the review of the NDA.

GeorgeTran1999

The FDA did not raise any concerns regarding etripamil clinical safety or efficacy data and highlighted two key Chemistry, Manufacturing and Controls (CMC) issues to be addressed: Company to submit additional information on nitrosamine impurities based on new draft guidance issued after the NDA submission; and An inspection is required at a facility that performs release testing for etripamil, to ensure it is in compliance with Current Good Manufacturing Practices. The facility changed ownership during the review of the NDA.

Ga_glovo

CRL...small CMC issues but nothing big, not rejected; they will have to resubmit again...3-6 months

Ga_glovo

only small CMC issue, this is not a decline

Ga_glovo

3-6 months probably. this is only a minor CMC issue because new rules were introduced during NDA review

stevenryl866

# FDA Issues Complete Response Letter for Etripamil for PSVT **Friday, 28****^(th)** **March at 7:00 am** *CRL focused on CMC; no clinical issues relating to etripamil raised* *$69.7M in cash, cash equivalents and short-term investments as of December 31, 2024*  MONTREAL and CHARLOTTE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- [Milestone^(®) Pharmaceuticals Inc.](https://www.globenewswire.com/Tracker?data=7gxsVOROaxXrGEykWxyYWBq-s7627-LHbAtQJfJmuLqnACRpPBmXS2-rTepWkKjvfhrMpjd6tLfQb4oMuyB4TZfyEouK-oU9BjEFPcm2RRTJufEk16viL2u0Xu5r3Lig) (NASDAQ: MIST) today announced the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for CARDAMYST™ (etripamil) nasal spray, a prescription medication in development for the conversion of acute episodes of PSVT to sinus rhythm in adults. The FDA did not raise any concerns regarding etripamil clinical safety or efficacy data and highlighted two key Chemistry, Manufacturing and Controls (CMC) issues to be addressed: * Company to submit additional information on nitrosamine impurities based on new draft guidance issued after the NDA submission; and * An inspection is required at a facility that performs release testing for etripamil, to ensure it is in compliance with Current Good Manufacturing Practices. The facility changed ownership during the review of the NDA. "We are deeply disappointed by the CRL but remain committed to the potential of CARDAMYST as a novel treatment option that can help patients with PSVT. Our team is evaluating the feedback provided and intends to request a Type A meeting to discuss the issues raised in the CRL," said Joe Oliveto, President and Chief Executive Officer of Milestone Pharmaceuticals. "We are appreciative of the FDA's efforts and are confident we can collaborate with the agency with the goal of addressing these issues in a resubmission." Milestone Pharmaceuticals had $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024.FDA Issues Complete Response Letter for Etripamil for PSVT

Puzzleheaded_Soil275

For God's sake at least roll to January in case they get CRLed for CMC reasons and Pdufa ends up being delayed a few months.

ai-moderator

# **TLDR** --- **Ticker:** X, STLD, CMC, TX, MT **Direction:** Up **Prognosis:** Long positions in all tickers due to bullish outlook on steel market driven by Trump tariffs and global factors. Potential for significant upside, especially in X due to acquisition possibilities. **Risk Factors:** China's steel exports, inflation, broader market downturn. **Author's Sentiment:** Very Bullish ( bordering on delusional) **Bonus:** Author is clearly long calls on STLD and other plays. Proceed with caution.

ai-moderator

# **TLDR** --- **Ticker:** X, STLD, CMC, TX, MT, CLF (and maybe SPY if you're feeling bullish) **Direction:** Up (mostly) **Prognosis:** Long positions across multiple steel companies. Author sees potential for significant gains driven by tariffs, global events, and industry consolidation. CLF is a high-risk, high-reward bet. **Trump Card:** Trump's return to power is a significant bullish factor for the steel industry according to this post. **China Factor:** China's steel exports are a major risk. **Additional Info:** The author provides detailed valuation ranges and considerations for various acquisition scenarios for X (a steel company). Includes charts and graphs supporting the analysis.

rerailed

+1 for CMC, largest rebar producer in the US with new mills coming online which have been under construction the last few years.

sirsplat

From a business perspective, they're the one I'm watching the most. They have a lot of plans for growth in the future with acquisitions and dipping into other metals such as aluminum, copper, and brass, which is much needed domestically. From a day to day perspective, they're actually the most reliable and easiest to deal with in my personal experience. They're not as established as NUE (the largest steel producer in North America) or CMC, but I think they're the better of those three. Not financial advice.

sirsplat

I'm a purchaser for a steel distributor out of Tennessee. Friday at the end of the work day, the steel tubing mills increased prices in the largest single jump since Covid. And they had already increased prices TWICE since the New Year. I was actively purchasing truckloads of steel when the websites for those companies shut down while they adjusted. If you're a small business or fabricator who uses a lot of steel, buckle up. Check out NUE, CMC, and STLD for some steel stocks to watch. The US gets a vast amount of steel coil and slabs for production from Mexico, Canada, and Brazil. We do not have the domestic capacity to keep up with current demand in the market. Supply will drop, and even if demand stays the same, prices are going to keep going up. If the pace continues, we will hit pandemic level prices again. If you are a fabricator and you have the space, stock up now. It's only going to get worse.

crazybutthole

You can argue that on the NFL subreddit but on an investment subreddit he seems to have done fine. If they didn't trade away CMC and Bryce Young turned out slightly better than he's shown - they might have won a couple more games.... but they are no where near a playoff caliber team with that roster.

Controversialtosser

Try Nucor or CMC instead. They are investing in brand new mills right now.

webthing01

Here are some of the American steel stocks listed on major U.S. stock exchanges, based on the information available: * ArcelorMittal (MT) - Although headquartered in Luxembourg, it's listed on NYSE and has significant U.S. operations. * Nucor Corporation (NUE) - Known for its steel production and scrap metal recycling facilities. * United States Steel Corporation (X) - An iconic American steel company with operations primarily in North America. * Steel Dynamics, Inc. (STLD) - An integrated steel company known for its mini-mills. * Cleveland-Cliffs Inc. (CLF) - Primarily an iron ore mining company but also involved in steel production. * Commercial Metals Company (CMC) - Engages in the manufacture, recycling, and marketing of steel and metal products. * Reliance, Inc. - Provides metal distribution services, including steel. * TimkenSteel Corporation (TMST) - Specializes in alloy, carbon, and micro-alloy steel products. * Friedman Industries, Inc. (FRD) - Manufactures and trades steel products. * Universal Stainless & Alloy Products, Inc. (USAP) - Produces specialty steels. * Ascent Industries Co. - Produces stainless steel pipes and other steel products. Please note, this list might not be exhaustive, as new companies might have entered the market or some might have changed their focus since the last update. For the most current and detailed information, you might want to do a real-time web search or check stock market listings directly.

Run4theRoses2

\-- you could have easily looked it up??? GPs has FDA Fast Track Approval on the RTOR - IDMC has been meeting with FDA. Gps Immunotherapy pristine Safety review in 4 Previous Phase 2 Trials, FDA TYPE C Meeting - already approved - GPs is a Project Orbis drug, and a registered Project Moon shot \- 6 Months to BLA Should See H2 2025 Revenue / 2026 2-$4B SELLAS Life Sciences Receives Favorable FDA Type C Meeting Feedback on Chemistry, Manufacturing, and Controls (CMC) Biologics License Application (BLA) Filing Strategy for Galinpepimut-S (GPS) 11/13/2023 – FDA feedback indicates Company’s CMC plans are in alignment with FDA’s requirements and expectations towards a BLA – – CMC regulatory alignment is critical step in approval pathway for GPS –

R0gu3tr4d3r

CMC Markets. You can short many currency pairs.

Agate_Seeker

They actually have many within the community that just submitted designs for merch. This is a dedicated community and team with CMC verification and a big CEX listing being announced tomorrow. 5300 telegram members as well

Agate_Seeker

Not even close. Been around for about a month. Survived big whale sell offs. Just got CMC verification and it's second CEX listing is going to be announced tomorrow. Has sustained around 7m mc this week after sustaining around 5m last week.

Adventurous-Date-397

I do think the CMC100 is an incredible idea. A market weighting of the top 100 cryptocurrencies. It’s been outperforming Bitcoin for years

MattieShoes

I sat down and did some reasonable thinking during the covid crash, figuring out who might benefit from what was coming. Several did very well. Bought united at peak panic, made like 40% in 11 days Fedex did well Held Zoom for about six months for over 270% gain Oil when it went negative Also bought BRK as kind of a safety pick near the bottom... Not flashy, but it felt extraordinarily un-risky during the crash and it's still outperforming. Also bought CMC and did very well. Also bought some semiconductor stocks that have done well (NVDA, AVGO, KLAC) So all in all, nothing absurd, but a very high win rate for 2020/2021.

AdriansOptions

ibkr - you just select you want to trade in Australia when it asks which geography you want access to, probably a fee for live quotes on ASX v other exchanges in US, but that will get you going, another one is CMC stockbroking

GordonGecko-1987

We all missed this… https://preview.redd.it/0hu4ceqcm6xd1.jpeg?width=1283&format=pjpg&auto=webp&s=75e765b9ed4e2cc98737cb442ffb0267f54d022b Statement of Commissioner Summer K. Mersinger Regarding Extension of No-Action Position from Certain Reporting Obligations September 25, 2024 I support an extension of the staff no-action position in Letter No. 20-30 from certain reporting obligations under the Commodity Futures Trading Commission’s\[1\] Ownership and Control Reports (“OCR”) final rules. However, I feel compelled to reiterate what I said last year when Commission staff extended this same relief: “I urge staff and the Commission to develop and issue an OCR proposed rulemaking soon—so that staff is not compelled to issue yet another extension when this one expires a year from now.”\[2\] Yet, here we are in exactly the situation I had hoped we would avoid—issuing another extension in a seemingly endless series of extensions instead of addressing a known issue head-on. Commission staff has taken a no-action position with respect to certain reporting obligations under the OCR final rules since 2014. But despite a petition to address this issue, we have spent the past decade repeatedly kicking the can down the road.\[3\] Instead of using Commission resources and staff time to issue unnecessary rules codifying existing expectations\[4\] or providing guidance to our most sophisticated markets on lightly traded contracts\[5\], maybe it is time to focus on fixing what is actually broken, like the OCR rules which are the subject of today’s no-action relief. \[1\] This statement will refer to the Commodity Futures Trading Commission as the “Commission” or “CFTC.” All web pages cited herein were last visited on September 24, 2024. \[2\] Statement of Commissioner Summer K. Mersinger Regarding Extension of Staff No-Action Position Regarding Ownership and Control Reports (September 22, 2023), available at [https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement092223b](https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement092223b). \[3\] Extension Letter at 1-2 (“Since 2014, \[the Division of Market Oversight (‘DMO’)\] has taken a no-action position with respect to reporting entities from certain reporting obligations under the OCR \[f\]inal \[r\]ule. In September 2017, DMO issued no-action letter 17-45 (‘NAL 17-45’).…. NAL 17-45 extended the time period for the no-action position, which was itself previously granted and extended in several prior no-action letters, from certain reporting obligations under the OCR \[f\]inal \[r\]ule…. Subsequent to the issuance of NAL 17-45, on June 14, 2018, \[the Futures Industry Association (‘FIA’)\] and \[the Commodity Markets Council (‘CMC’)\] submitted a petition to the Commission, which requested, among other things, that the Commission codify the no-action positions provided in NAL 17-45…. As of the date of this letter, the Commission has not acted upon FIA and CMC’s petition…. On September 25, 2020, DMO issued no-action letter 20-30 (‘NAL 20-30’), which extended the no-action position in NAL 17-45. On September 22, 2023, DMO issued no-action letter 23-14 (‘NAL 23-14’), which extended the no-action position in NAL 20-30 with respect to each obligation covered by NAL 23-14 ‘until the earlier of: (a) the applicable effective date or compliance date of Commission action addressing such obligation or (b) September 30, 2024.’ Therefore, without further action by the Commission, by its terms NAL 23-14 will expire on September 30, 2024.” (emphasis added). \[4\] See Dissenting Statement of Commissioner Summer K. Mersinger Regarding Amendments to Part 40 of the CFTC’s Regulations (September 12, 2024), available at [https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement091224b](https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement091224b). \[5\] See Dissenting Statement of Commissioner Summer K. Mersinger on Guidance Regarding the Listing of Voluntary Carbon Credit Derivative Contracts (September 20, 2024), available at [https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement092024](https://www.cftc.gov/PressRoom/SpeechesTestimony/mersingerstatement092024). \-CFTC-

MyCactusTeacher

CMC still out. Purdy too limp

OtherCommercial5982

Hello. I am looking to start my investing journey as I am turning 18 in a weeks time. Researching on different types of brokers, and came across CMC markets which states $0 brokerage on the ASX\* and when you trade stocks in the US, UK, Canada and Japan.  The asterisk sates *First buy under $1,000 per stock per day. Excludes margin loan settled trades.* I am just not sure what it means by first buy under 1,000. Does this mean that the $0 fees only lasts for only the first time only? Any clarification would help thank you.

Soupkitchentomorrow

CMC 1TD Aiyuk 1TD CMC 50+ Rushing Hall 50+ rushing Will literally print tonight, you’re welcome.

Substantial_Oil_2330

You are right about the minimum buy off 500 dollars. But I still can't use CMC due to it not supporting fractional shares. This is really important for me. I can do an initial deposit of 500 but ordering 1 share instead of how much money I want is a bit annoying to me. I was looking for alternatives and found webull. I know you said that it was involved in some controversies but I did a little research and saw that it is all insured by America. Meaning that the app itself is Chinese but the actual broker is registered in New York. I believe webull is safe but just wanted to get your opinion on it. The reason I'm so eager to use Webull is because after a while of research it was the only app I could find that had free brokerage on ETF's which is going to make up like 95% of my portfolio. Thanks would just be interested on your take!

qsxpkn

WeBull. I use other some other brokers as well I've found WeBull to be very impressive compared to IBKR or CMC.

Winning--Bigly

Yes his CMC stint had a lot of unvested options. But that wasn’t even my point. He’s set for life with an upfront payment of $10M.

Free_Raccoon3402

CMC Market, It’s free brokerage on each ticker up to $1000 a day, and chess sponsored ((:

Next-Lab653

What do you think, for investing as an Australian in shares and etfs- US shares - IBKR AU shares - Trading 212, etoro or CMC? (bit inclined for AU shares towards CMC after reading various threads and research but cant find much about trading 212 or eToro negatives)

Next-Lab653

What do you think, for investing as an Australian in shares and etfs- US shares - IBKR AU shares - Trading 212, etoro or CMC? (bit inclined for AU shares towards CMC after reading various threads and research but cant find much about trading 212 or eToro negatives)

Next-Lab653

What do you think, for investing as an Australian in shares and etfs- US shares - IBKR AU shares - Trading 212, etoro or CMC? I am confused and would really appreciate some help.

Next-Lab653

What do you think, for investing as an Australian in shares and etfs- US shares - IBKR AU shares - Trading 212, etoro or CMC? I am confused and would really appreciate some help.

Next-Lab653

What do you guys think, for investing as an Australian in shares and etfs- US shares - IBKR AU shares - Trading 212, etoro or CMC?

31513315133151331513

The rates will change depending on who's loaning the shares, but I usually check my broker and [ComaniesMarketCap.com](https://companiesmarketcap.com/sirius-xm/cost-to-borrow/#:~:text=Latest%20borrow%20fee%20for%20Sirius,Brokers%3A%2071.3964%25%20(annualized)&text=The%20cost%20to%20borrow%20%2F%20borrow,borrowing%20shares%20of%20a%20stock). Right now CMC, who claims to use IBKR as a source shows no rate because they show zero shares available to borrow. Schwab shows >350k available at a rate of \~240%. You may get different results from different sources, but they all seem to show high rates IF they even have shares to loan.

RayInBlacky

Commenting on this 2 YO posting - I got introduced to WK 2 days ago since my nephew is now working for them. Just started the 30 day trial today with $250 so will test them out. I can see some contributors haven't been happy - I've got accounts with CMC, eToro, Stake and Vanguard and all three have given me trouble at some stage (eToro being the worst - testing cash out and took weeks to get my funds). But nothing compares to the problems people have had with Crypto sites over the years, including that "New Zealand" company that went bust owing millions.

JCOHU

I'm 24 and have just moved to Australia. I'm looking to invest roughly $1,000 a week via CMC for the long term. Currently, I'm thinking of splitting it as follows: VOO 75%, QQQ 10%, IOO 10%, IBIT 5%, and just forgetting about it. Previously, I had invested in just VOO 80% and VYM 20%. Do people have any thoughts on this, or does this new split seem solid?

PhoenixFira

CMC and on madden cover lets gooo 🎉

arch1inc

LKQ just lowered guidance for 2024-2025 for their scrap and repair side of business. But other companies like CMC and CWST are doing fine there and near all time highs. Worth noting these companies dont have operations issues like GW AV. They continue to deliver each quarter unlike Danny who has been milking the second shredder news for literally 2 years now. Since I made this post the stock has dropped 40 percent, a reverse split has been PR’d which I mentioned would happen, and the company has been radio silent addressing shareholder concerns (shocker). Im not sure what else it will take for people to realize what is going on here. The CEO is wanting to approve 400,000,000 shares in warrants by july 19th as well, which means after reverse split he will just tank the stock further again (source: pre14a filed last week, proposal 3). And because he is majority holder he can vote it through, just like the reverse split vote on may 20th. There are many better pennies that are profitable and communicative that people can invest in that are undervalued. Im not sure why people want to invest in messy trash companies like these that have literally ruptured and lost over 300,000,000$ in under a decade with very little to show for it.

geekywarrior

You'll always wish you bet on the horse that won. I'll always wish I picked CMC when he *fell* to me at 1.02 last year. I'll always wish I spent more than 2 minutes reading the article about bitcoin in 2009. I can go on and on, but you get the picture. No point in letting yourself get haunted by not knowing the future.

TicketronTickets

Catalysts and positives for IBRX 1) 20,000 doses ready to be distributed which is the inventory for one year. Each does costs $35,000. Assuming that 80% of that will be paying customers we will have a revenue of $560 Million for the first year. 2) Rollout will begin on May 6th. 3) Secured BCG supply for one year and have other options in place incase of supply issues. 4) 23 Global sites activated for international expansion. 5) All International Strategic Partners have shown great interest. 6) $240Million cash on hand. Sufficient until revenue generation. No additional funding needed. 7) Front ran most financial commitments, Moonshot, CMC and Inventory buildup behind us. 8) 54 new Sales and Marketing Access Team hired, trained and Certified for 5 sales regions in the US. 9) Lunch with major presence in San Antonio, TX (beginning of May) and Chicago, IL (beginning of June) 10) Improved results from the completed Phase II non-small lung cancer trail. This may fast track FDA registration and hopefully approval.

Controversialtosser

Theres a lot more players than just US steel in the industry. Cleveland Cliffs, Nucor, ATI, CMC etc.

1_BigPapi

Yahoo sources data from CMC, which is owned by Binance I believe, so it probably references their exchange data. You can source older data elsewhere. Not a big deal, just noting in case you want to update.

the_snook

CMC Markets Invest does no commission on the first buy order up to $1000 per day. All sales are minimum $11 commission though.

CanFixGuns

Same here. My $DWAC is showing zero shares held. And $DJT is not even searchable this is on the CMC Markets app

nbelyh

On EU markets (FRANKFURT) Ukrainian bonds are open. You could try some broker other than IB that works with that (CMC Markets for example). Ukrainian bonds on FRANKFURT: [https://www.boerse-frankfurt.de/bonds/search?COUNTRIES=UA](https://www.boerse-frankfurt.de/bonds/search?COUNTRIES=UA)

VegasBjorne1

Materials… I got into CMC, FCX, AEM and SCCO in the last 2 weeks.

StinkyPinkk

Form 10-K filed on March 1,2024 has some insight to the acquired biotech company ModeX that will have multi-specific antibodies developed using MSTAR technology platform and is anticipated to enter preclinical and CMC development stage in 2024. I’m not too entirely sure how much of a catalyst this could be but it’s something to look out for I’d imagine.

AmateurProtagonist

Boring Money do some good comparisons [https://www.boringmoney.co.uk/](https://www.boringmoney.co.uk/) and MoneySuperMarket do a few reviews too [https://www.moneysupermarket.com/investments/stocks-shares-isas/results/](https://www.moneysupermarket.com/investments/stocks-shares-isas/results/) HL typically is the most expensive unless you have a smaller <£50k portfolio, but even then there are cheaper providers who are a bit more "modern". I've had an account there, and often been forced to have my auto enrolment pension through them, and I've never been a fan (just a personal view.) If you only buy Vanguard funds then their own platform will often be the best pick. Annoying they charge you when you only can invest in their own products but that's life sometimes! Assuming you are investing via ETFs you can also look at Trading212, Freetrade, and CMC Invest (the last two are also looking at/have classic funds too.) One provider you might be surprised about is AJ Bell, they have some scaling fees but often they are capped, meaning you can snag a pretty good deal if you know what you invest in, and how often. Using their regular investing solution to cut costs helps in a big way (same for most providers so check that out too.) If you want just funds and ETFs (a few equities) then checkout Dodl which is made and owned by AJ Bell but it's their "entry level" brand but still gives a tone of flexibility at a very low price point. ii also has a fund only tier which is pretty price competitive, and they have a more modern experience compared to the other incumbents. Personally, I use CMC Invest for my ISA and GIA (I got a promo so reduced the £120 a year down) but previously I was AJ Bell (was ii before then.) My SIPP I have with Moneyfarm so I'm more hands off but again got a good deal on the management fees. Worth keeping your eyes open for the switcher deals everyone should be offering around now. The lead up to April should have everyone offering cash back or discounted fees for transferring your account.

CarpeLivem

OT, first possession… What kind of 3rd & 4 play was that from Shanahan? Looked exactly like Harbaugh / Kapernick’s weird high arc play against the ravens. Just run it with Mitchell who was fresh Then 1st and goal, go with CMC to score a TD.

skin_flute_player

CMC getting mvp regardless who wins tonight

A55_Cactu5

I said CMC would get the first TD

A55_Cactu5

CMC is the one

1TalefromTheCryptos

I hedged CMC to cover my other higher payout players.

TheNotoriousNIL

Anytime TD CMC, Aiyuk, and Kelce, 50yds + rushing Pacheco

unlikelycandidates

agree, playoff mahomes is definitely different.. they beat some some of the best teams in the playoffs to get to the SB too. I'm counting on CMC, Deebo, and Aiyuk to have a good game.. and as long as purdy can hold his own and not throw m(any) picks, 49ers just might have a decent shot at this

Malefic-Angel

Chiefs ML CMC anytime TD Kelce anytime TD Pacheco 50+ yards

TheNotoriousNIL

Anytime TD on CMC and Kelce and Aiyuk